Phase 1 Vaccination Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults

Respiratory Syncytial Virus VaccinationHuman Metapneumovirus VaccinationParainfluenza Vaccination

Clover Biopharmaceuticals AUS Pty192 enrolled1 locationNCT06984094

Completed

Phase 1

A first-in-human study to evaluate the safety, tolerability and performance of uncoated and placebo-coated Nanopatches

Vaccination Delivery Device

Vaxxas Pty Ltd18 enrolled1 locationACTRN12615000583549

Not Yet Recruiting

Phase 1

ProVac:Probiotic adjuvant to enhance the efficacy of pnemococcal vaccination: A pilot study.

Healthy infant immune response to the PCV13 pneumococcal vaccination

Associate Professor Mimi Tang30 enrolled1 locationACTRN12613000368730